Brief: Genetic Signatures Says Quarterly Sales Down 12% From Preceding Quarter
30/01/2023 01:50
Jan 30 (Reuters) - Genetic Signatures Ltd GSS.AX :
* QUARTERLY SALES OF A$4.7 MILLION; DOWN 12% FROM PRECEDING
QUARTER
Source text for Eikon: ID:nASX4mk0PF
Further company coverage: GSS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genetic Signatures
See all newsBrief: Genetic Signatures Says Anne Lockwood To Conclude As Interim Managing Director
Brief: Genetic Signatures Logs Q3 Sales A$3 Mln
Australia's Genetic Signatures extends gain on deal with Danish hospital
Australia's Genetic Signatures jumps on supply agreement with Denmark hospital
Brief: Genetic Signatures Signs Danish Supply Agreement